News & numbers


Pharmaceutical dose packaging market 14.7%


$26.1bn


Value of the pharmaceutical unit dose packaging market by the end of 2021. It registered a double-digit year-on-year growth between 2020 and 2021.


The CAGR at which pharmaceutical unit dose packaging sales will surge by between 2021 and 2031.


87%


Dose sales that the US accounts for in North America in 2021, largely through the presence of several leading players in its borders.


15%


Year-on-year growth for dose packaging in the UK in 2021. This increase has been facilitated by rising research and development initiatives.


75–85%


Proportion of the pharmaceutical unit dose packaging market that tier 3 manufacturing companies hold. Those key players also contribute almost 15–25% of the global demand.


100 million


Number of vials that global non-profit organisation Coalition for Epidemic Preparedness Innovations (CEPI) ordered from Stevanato Group, one of those pharmaceutical dose packaging manufacturing key players.


Source for all: Future Market Insights Packaging & Converting Intelligence / www.pci-mag.com 7


2 billion


Number of Covid-19 vaccine dosage vials that Schott – another key player – was ordered to manufacture in 2020.


VectorSun; SpicyTruffel/Shutterstock.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53